Meeting
2020 Genitourinary Cancers Symposium
The Personalized Medicine for Prostate Cancer (PMPC) Study: The role of race, genomics, and patient complexity in treatment outcomes.
Authors
Sheldon Greenfield
University of California, Irvine; Health Policy Research Institute, Irvine, CA
Sheldon Greenfield , Edward M. Uchio , Mark S. Litwin , Gregory Gin , Isla Garraway , Timothy J. Daskivich , Harwood Garland II, Sherrie H. Kaplan
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Patient-Reported Outcomes and Real-World Evidence
Clinical Trial Registration Number
NCT03770351
Citation
J Clin Oncol 38, 2020 (suppl 6; abstr 302)
Abstract #
302
Poster Bd #
L8
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Genitourinary Cancers Symposium
Correlation of age and the tumor transcriptomic profile in patients (pts) with advanced prostate cancer (PCa).
First Author: Kamal Kant Kant Sahu
Poster
2019 Genitourinary Cancers Symposium
A 17-gene genomic prostate score as a predictor of adverse pathology for men on active surveillance.
First Author: Zachary Kornberg
Poster
2019 Genitourinary Cancers Symposium
Molecular characterization of longitudinally tracked prostate cancer foci in men on active surveillance for low risk disease.
First Author: Jeffrey J. Tosoian
Poster
2018 Genitourinary Cancers Symposium
Are all biopsies created equal? comparison of extended sextant prostate biopsies performed with and without MRI-TRUS fusion biopsy system.
First Author: Graham R. Hale